CRUSH!!MDS - A phase 2 study of SGI-110 in Philadelphia-negative myeloproliferative neoplasms

1 Pogledi
administrator
administrator
07/29/23

Dr. Pinkal Desai Discusses a Clinical Trial of SGI-110 for Patients with Myelodysplastic Syndrome, Myeloproliferative Neoplasms, Chronic Myelomonocytic Leukemia to learn more & participate in a clinical trial visit crushmds.org

  • Kategorija

Prikaži više

0 Komentari Poredaj po

Nema komentara

Komentari na Facebooku

Sljedeći